Get started
Author

Anita I. Kapanen

Observed names: A I Kapanen, A Kapanen, A. Kapanen, A.I. Kapanen, Anita I Kapanen, Anita Kapanen, Kapanen, Anita I.
Observed institutions: BC Cancer Agency, University of British Columbia, Tampere University, Tampere University Hospital, University of Tampere, University of Oulu
ORCID: 0000-0001-6091-9818
Observed ORCID: 0000-0001-6091-9818
OpenAlex ID: A5068569848
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab
2005 · M. Tanner, M. Hollmén, et al. · Annals of Oncology · 667
Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line
2005 · Peter Nagy, Elza Friedländer, et al. · Cancer Research · 528
PDF
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer
2004 · Minna Tanner, Anita I. Kapanen, et al. · Molecular Cancer Therapeutics · 276
PDF
Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture
1998 · Q. Qu, M. Perälä-Heape, et al. · Bone · 244
Trastuzumab causes antibody-dependent cellular cytotoxicity–mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance
2007 · Márk Barok, Jorma Isola, et al. · Molecular Cancer Therapeutics · 234
PDF
Effect of nickel–titanium shape memory metal alloy on bone formation
2001 · Anita Kapanen, Jorma Ryhänen, et al. · Biomaterials · 136
Behaviour of Nitinol in osteoblast-like ROS-17 cell cultures
2002 · A Kapanen, J Ilvesaro, et al. · Biomaterials · 110
Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer
2013 · Wieslawa H. Dragowska, Sherry A. Weppler, et al. · PLoS ONE · 100
PDF
Development of a liposomal nanoparticle formulation of 5-Fluorouracil for parenteral administration: Formulation design, pharmacokinetics and efficacy
2010 · Anitha M. Thomas, Anita I. Kapanen, et al. · Journal of Controlled Release · 79
Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs
2007 · Gigi N.C. Chiu, Lincoln A. Edwards, et al. · Molecular Cancer Therapeutics · 61
PDF
Patient values and preferences for antithrombotic therapy in atrial fibrillation
2017 · Peter S. Loewen, Angela Tianshu Ji, et al. · Thrombosis and Haemostasis · 53
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-κB, p53, bax, and p27 levels
2008 · Catherine A. Tucker, Anita I. Kapanen, et al. · Molecular Cancer Therapeutics · 45
TGF-β1 secretion of ROS-17/2.8 cultures on NiTi implant material
2002 · Anita Kapanen, Anne Kinnunen, et al. · Biomaterials · 34
Serum proteomics in multiple sclerosis disease progression
2015 · Helen Tremlett, Darlene L.Y. Dai, et al. · Journal of Proteomics · 33
The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity
2011 · Wieslawa H Dragowska, Sherry A Weppler, et al. · BMC Cancer · 28
PDF
Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1
2007 · Karin Rennstam, Göran Jönsson, et al. · Cancer Genetics and Cytogenetics · 26
PDF
Effect of metal alloy surface stresses on the viability of ROS-17/2.8 osteoblastic cells
2002 · Anita Kapanen, Anatoli Danilov, et al. · Biomaterials · 22
Evaluating the Effect of a Patient Decision Aid for Atrial Fibrillation Stroke Prevention Therapy
2019 · Peter S. Loewen, Nick Bansback, et al. · Annals of Pharmacotherapy · 20
Multivalent Rituximab Lipid Nanoparticles as Improved Lymphoma Therapies: Indirect Mechanisms of Action and In Vivo Activity
2011 · Jesse Popov, Anita I Kapanen, et al. · Nanomedicine · 18
Workplace cardiovascular risk reduction by healthcare professionals—a systematic review
2021 · E Z Zusman, A I Kapanen, et al. · Occupational Medicine · 12
Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study
2021 · Shahrzad Salmasi, Adenike Adelakun, et al. · CJC Open · 12
PDF
Oral anticoagulant adherence and switching in patients with atrial fibrillation: A prospective observational study
2022 · Shahrzad Salmasi, Abdollah Safari, et al. · Research in Social and Administrative Pharmacy · 10
Atrial fibrillation patients’ experiences and perspectives of anticoagulation therapy changes
2020 · Shahrzad Salmasi, Anita I. Kapanen, et al. · Research in Social and Administrative Pharmacy · 10
Cardiovascular Risk Reduction in the Workplace With CAMMPUS (Cardiovascular Assessment and Medication Management by Pharmacists at the UBC Site)
2019 · Barbara Gobis, Anita I. Kapanen, et al. · Annals of Pharmacotherapy · 10
Bone morphogenetic protein 3b expressing reindeer antler
2001 · A. Kapanen, J. Ryhänen, et al. · Journal of Biomedical Materials Research · 9
Works count: 59
Citation count: 2,852
H-index: 18
I10-index: 24
Year
Topic
Type